First-pass extracted concept

quality-by-design framework

Candidate: concept label2 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

QbD

Evidence Snippets

We compared three manufacturing methods for diclofenac-loaded liposomes: probe sonication, microfluidic mixing, and a high-turbulence microreactor, under a Quality-by-Design framework.

Evidence 1Source 1DOI PubMedprovenance

The implementation of a quality-by-design framework is the heart of the AAV-based gene therapy manufacturing process.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2primary paper2025MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1process windowsupports2026Source 1DOI PubMed

Differential scanning calorimetry supported a 70-85 °C processing window for the lipid excipients.

Quoted textsource-backed

DSC supported a 70-85 °C processing window.

Claim 2benefit statementsupports2025Source 2DOI PubMed

A data-driven quality-by-design approach mitigates process inconsistency and provides the foundation for process validation and regulatory compliance in AAV manufacturing.

Claim 3prerequisitesupports2025Source 2DOI PubMed

Rigorous process characterization using validated scale-down models and design of experiments is a prerequisite for establishing a robust control strategy with defined proven and normal operating ranges.

Claim 4workflow prioritysupports2025Source 2DOI PubMed

A quality-by-design framework is central to the AAV-based gene therapy manufacturing process.